. 2018 Mar 15;476(6):1240–1249. doi: 10.1007/s11999.0000000000000245
© 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Association of Bone and Joint Surgeons
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Table 3.
Characteristics of patients who received bisphosphonates after diagnosis of ONFH
